Effects of policosanol (10 mg/d) versus aspirin (100 mg/d) in patients with intermittent claudication: a 10-week, randomized, comparative study.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/18388038
Conclusion of this study
In conclusion, treatments of policosanol, not aspirin, for 10 weeks significantly increased walking distances, but modestly, in contrast with previous results. Therefore, the duration of treatments at the doses tested was too short for meaningful effects on the treadmill test.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study